ABUS vs GILD: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Gilead Sciences Inc in 2026
ABUS
Arbutus Biopharma Corp
—
GILD
Gilead Sciences Inc
$129.83
Key Metrics Comparison
| Metric | ABUS | GILD | Winner |
|---|---|---|---|
| Market Cap | $882.99M | $160.15B | GILD |
| P/E Ratio | 5.39 | 17.55 | ABUS |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABUS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or GILD a better investment?
Comparing ABUS and GILD: Arbutus Biopharma Corp has a market cap of $882.99M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and GILD?
ABUS (Arbutus Biopharma Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or GILD?
Based on P/E ratios, ABUS trades at a lower multiple (5.4x vs 17.5x).
Which is growing faster: ABUS or GILD?
Both ABUS and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABUS or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABUS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $882.99M for ABUS.
Should I buy ABUS or GILD in 2026?
Both ABUS and GILD have investment merit. ABUS trades at $N/A while GILD trades at $129.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and GILD stock?
Key differences: Market Cap ($882.99M vs $160.15B), P/E Ratio (5.4x vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABUS or GILD in 2026?
The choice between ABUS and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABUS and GILD?
ABUS (Arbutus Biopharma Corp) has a market cap of $882.99M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.